Member Info for Laura2022

Blue

Very little on ask again and noq bidding well above 0.15l

Block buying again

Can they only just realise they need urgent money ??!!

We’re thrilled to announce that J. Fernando Corredor has joined Polarean as Area Sales Director for the Western U.S.

Based out of San Francisco, Fernando is a seasoned medical sales executive with over 25 years of experience helping MedTech startups grow and bringing innovative technologies to healthcare providers. His background spans groundbreaking solutions in intraoperative MRI, portable CT, AI in medical imaging and pathology, and rapid intraoperative pathology.

Throughout his career, Fernando has contributed to companies later acquired by Medtronic, Integra LifeSciences, Samsung, and Tempus Labs—building deep expertise in imaging, radiation oncology, and collaborations with leading academic and cancer centers across the Western region.

Another 10mln

On a very quiet AIM weeke they are offering nearly 0.15p bid for 15mln shares yet only allowing 1-2mkn to be bought at 0.16p

They know

Haz20

Look at what happened at WHI ( I'm 200% u there)

Big holders stepped in

Your post seems to have gone ?, here is the summary yoi asked for

Presentation notes Sept 2025

Key growth in all areas , particularly bio statistics, CEO very pleased and very confident about the niche growth markets many of which are now mandatory under EU law and most could well become mandatory for drug design. Positive regulatory environment eg FDA

[ ] Key market drivers

* model informed discovery/bio stats help

> costs $2.5bln and 10-15yrs to get drug to market and less than 5% success rate - PYC modelling drastically cuts this and using MMID/BS can

1) save $100-500mln

2) increase to 20-30% success at Phase II

3) 30-50% fewer patients

[ ] Key growth/CAGR markets which PYC operate

MMID 18% CAGR with market set to be $13bln

Biostatistics 24% CAGR $40bln market

Personalised medicine 7.5% CAGR and largest market is North America ( partner DoseMeRx based there)

General overviews

Costs at just 3% therefore tracking or below inflation in 2025 so very tight cost mgmt

Total Income at 3yr high and bolstered by moving into new therapeutic areas such as immunology and cardiovascular

Just after year end received £250,000 + and will recieve £60k grant, therefore cash position as of July was almost £800,000

Have applied for other grants and will announce if/when progressed

Conversion rate 2022-2024 was 27%

Conversation rate 2025 jumped to 45%

6 late stage contracts due

The "right team" now finally assembled in all key growth areas

Excited for future

Peer comparisons

APTA £35mln cap and £1.2mln full year revs( = x 30 annual rev)

FAB £17 mln and £1.96mln full year ( x 9)

PYC £1.4mln and £0.85mln full year ( x less than 2 )

IMM £60mln cap (pre revenue)

GENI (£10mln) revenues £1.6mln, losses £2.4

Into close

Could buy 1.5mln, could sell 15mln

Shows where this is heading...particularly if an orders RNS comes or positive news on future diredtion , takeover etc

Charts most over sold in 3yrs, large holders in control

Even with cash burn they still have c $5mln cash as of Nov 2025

They have 6-9mth runway till end Q22026 at least

They have won 3 orders in last 2mths

I can see Philpps or medical imaging company making an offer

Mgmt won't get 75% backing for this "proposal '

Cash and cash equivalents of US$7.3m as at 30 June 2025

Delayed trade it looks

Thanks Trench/KingH

Cannot buy but can sell 20mln

Mickey

Real spread 0.151 to 0.159p

Will offer x 5 what is avaliable to buy

News lands this does 200%

Its getting to make or break

So oversold, why do people think CORA haven't issued any kind of statement yet?

Do people think the mine is still CORAs and won't be taken ?

Tia

KingH

Could DoseMeRx make an offer for PYC?

Now nearly 0.15p for 20mln

Something is happening

Shipsunk

Good point

Charts most over sold in 3yrs, large holders in control

Even with cash burn they still have c $5mln cash as of Nov 2025

They have 6-9mth runway till end Q22026 at least

They have won 3 orders in last 2mths

I can see Philpps or medical imaging company making an offer

Mgmt won't get 75% backing for this "proposal '

Cash and cash equivalents of US$7.3m as at 30 June 2025

As has shown with WHI which is now 200% up for me, POLX could follow the example of GDR and WHI from their lows of 0.2p and 0 45p respectively

Yes

That's the problem with some of these opaque holdings/controlling parties